MiNK Therapeutics, Inc.

NASDAQ:INKT

Biotechnology

Healthcare
$10.22 -2.87%

-$0.35 today

Market cap
$52.17M
Beta
0.47
P/E (TTM)
-4.6
EPS (TTM)
-$2.60
52W Low $6.80High $76.00

Volume 0.01M

Average 0.05M

Balance Sheet

Inspect the capital base behind the business.

Assets

$14.24M

FY 2025 · Annual

+148.9% YoY

Liabilities

$28.47M

FY 2025 · Annual

+12.5% YoY

Equity

-$14.23M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents38.89M19.64M3.37M4.58M13.36M
Short-term Investments00000
Net Receivables23K0000
Inventory00000
Other Current Assets721.32K470.3K177.96K164.24K211.2K
Total Current Assets39.63M20.4M3.6M4.99M13.85M
Property, Plant & Equipment (Net)606.6K1.07M953.98K732.93K390.87K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets606.6K1.07M953.98K732.93K390.87K
Total Assets40.24M21.47M4.55M5.72M14.24M
Account Payables3M5.82M3.91M2.73M3.43M
Short-term Debt00005.18M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities5.76M5.21M5.66M3.51M2.85M
Total Current Liabilities16.47M12.68M11.4M6.96M13.03M
Long-term Debt0004.92M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities09.19M11.21M13.42M15.44M
Total Non-current Liabilities09.19M11.21M18.35M15.44M
Total Liabilities16.47M21.87M22.61M25.31M28.47M
Common Stock3353393464048
Retained Earnings(82.95M)(110.94M)(133.4M)(144.18M)(156.68M)
Accumulated OCI(625.27K)(292.47K)(430.95K)(631.58K)(718.92K)
Other Stockholders Equity0900000
Minority Interest00000
Total Equity23.78M(401.3K)(18.06M)(19.59M)(14.23M)
Total Debt0004.92M5.18M
Net Debt(38.89M)(19.64M)(3.37M)347.57K(8.18M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$9.5M
Other Current$496.8K
Total Current Assets$10.0M
PP&E (Net)$354.5K
Total Non-current Assets$354.5K
Total Assets$10.4M

Analysis

Selected assets total $10.4M for Latest. The largest visible component is Cash & Equivalents at $9.5M, about 91.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 14, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipSep 2, 2026

How much cash does INKT have?

MiNK Therapeutics, Inc. (INKT) reported $13.36M in cash and equivalents in fiscal 2025.

How much debt does INKT carry?

MiNK Therapeutics, Inc. (INKT) reported $5.18M of total debt, with net debt of -$8.18M.